NewslettersProstate Cell NewsDocetaxel Radiosensitizes Castration-Resistant Prostate Cancer by Downregulating CAV-1By Laurisa Dohm - February 1, 2024050The authors investigated the effectiveness and molecular characteristics of Docetaxel and radiation combination therapy in vitro.[International Journal Of Radiation Biology]AbstractGraphical Abstract